• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
Health
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
By Matthew Perrone and The Associated PressDecember 18, 2022
FDA
Health
The FDA’s speedy approval of experimental new drugs came to a screeching halt this year
By Matthew Perrone and The Associated PressDecember 7, 2022
Man with IV
Health
If you have hemophilia, you can now get a one-time gene therapy for $3.5 million
By Matthew Perrone and The Associated PressNovember 23, 2022
Juul
Retail
Layoffs aren’t just hitting tech. Juul is eliminating hundreds of jobs.
By Matthew Perrone and The Associated PressNovember 10, 2022
Jeffrey Reed
Health
Philips told millions of people it will eventually replace their sleeping devices that emit hazardous chemicals. That was over a year ago.
By Matthew Perrone and The Associated PressOctober 25, 2022
Juul to pay nearly $440 million to settle states’ investigation into marketing of its e-cigarettes to teens
Health
Juul to pay nearly $440 million to settle states’ investigation into marketing of its e-cigarettes to teens
By Matthew Perrone, Dave Collins and The Associated PressSeptember 6, 2022
Hearing aids
Health
FDA approves over-the-counter hearing aids in the U.S.
By Matthew Perrone and The Associated PressAugust 16, 2022
JUUL
Finance
Altria invested $13 billion in Juul. As the U.S. moves to ban e-cigarettes, their value has gone up in smoke
By Matthew Perrone and The Associated PressJuly 28, 2022
Birth Control Pills
Health
Pharma company asks to be the first to sell its birth control over the counter
By Matthew Perrone and The Associated PressJuly 11, 2022
Paxlovid COVID-19 pill
Health
The FDA is allowing pharmacists to prescribe COVID-19 pill Paxlovid
By Matthew Perrone, Tom Murphy and The Associated PressJuly 6, 2022
FDA bans Juul e-cigarettes
Health
FDA bans Juul e-cigarettes amid spike in teen vaping
By Matthew Perrone and The Associated PressJune 23, 2022
A nurse prepares a pediatric dose of the Pfizer-BioNTech Covid-19 vaccine.
Health
FDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
By Matthew Perrone, Lauran Neergaard and The Associated PressMay 5, 2022
Man receives Pfizer COVID vaccine
Health
FDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By Lauran Neergaard, Matthew Perrone and The Associated PressMarch 29, 2022
Moderna vaccine full FDA approval
Health
Moderna COVID-19 vaccine gets full approval from the FDA
By Matthew Perrone and The Associated PressJanuary 31, 2022
Merck covid 19 pill
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
North America
DOJ is turning to an ancient body of law to capture Iranian oil tankers. It’s been so long since the U.S. used it, 'we’d have to conduct a séance'placeholder alt text
By Sasha RogelbergAugust 28, 2026
Personal Finance
An 87-year-old American billionaire bought the first Ferrari Luce for $40 million, and the purchase could save him $13 million in taxesplaceholder alt text
By Sasha RogelbergAugust 28, 2026
Politics
DeSantis administration diverted $10 million meant to help poor children, Florida grand jury findsplaceholder alt text
By Jim Vertuno and The Associated PressAugust 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.